Even though discounted playing cards might help alleviate the burden of substantial drug expenditures while in the short term, they do not handle the systemic concerns driving up prescription prices in the U.S. Broader policy changes could deal with the root causes of soaring drug prices, like lack of transparency in pricing as well as role of inte